Workflow Services, a US-based platform to enable pharmacist-led clinical services, announced on Tuesday the successful completion of a one-year pilot and a nationwide expansion of its Colorectal Cancer Screening Education Program.
The aim of this initiative is to educate patients about the significance of colorectal cancer screening in the pharmacy setting. The program is intended to bridge the gap in preventive care because of the community pharmacy's unique position as many Americans' most accessible, trusted and frequently visited healthcare provider. In the pilot, 92% of the participating pharmacists reported increased proficiency in their ability to educate patients about the effect of colorectal cancer screening.
Following the pilot program's success, pharmacies across the country will now be able to use the Workflow Services platform to combine colorectal cancer screening education into their patient encounters.
Kevin Houlihan, Workflow Services president and CEO, said: "The data we collected in the pilot shows that we are unlocking a new, impactful healthcare channel. Access is one of the major challenges currently confronting the American healthcare system. And we've seen that by providing pharmacists with the right tools and guardrails in a platform like Workflow Services, we can make a real difference in closing care gaps and driving health outcomes."
Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011
D3 Bio completes USD108m Series B financing round
Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Champions Oncology expands bioanalytical services with new technology and leadership
Poolbeg Pharma trial to feature in major CRS research programme
PureTech clears key FDA milestone for Phase 3 development of deupirfenidone
Natera acquires Foresight Diagnostics to expand MRD capabilities